MENU
NRSN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NeuroSense Therapeutics (NRSN) Ownership - Who owns NeuroSense Therapeutics?
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others... Show more
Profile
Industry
N/A
Address
11 HaMenofim Street, Building B
Phone
+972 97996183
Employees
14
Web
https://www.neurosense-tx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
21.34M
P/E Ratio
N/A
Total Cash
344K
Projected Growth
N/A
Total Debt
19K
Revenue
N/A
Risk (Beta)
1.27
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NRSN
Capitalization
21.3M
P/E Ratio
N/A
Risk (Beta)
1.27
Dividend Yield
N/A
Total Cash
344K
Total Cash/Share
0.01
Total Debt
19K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-2.82M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.76
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
0.21
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-10.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-400.91
Shares Held By Institutions
793K
Shares Outstanding - Current
23.2M
Total Liabilities
3.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-23.450
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11 HaMenofim Street, Building B
Phone
+972 97996183
Employees
14
Web
https://www.neurosense-tx.com